United States · FDA National Drug Code directory
Eslicarbazepine Acetate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59746-719_196ec23c-8453-4396-b6c4-d6934a418787
- Product NDC
- 59746-719
- Form
- TABLET
- Composition / generic term
- eslicarbazepine acetate
- Labeler
- Jubilant Cadista Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260501
- Source listing expiry
- 20271231
Source-listed ingredients
- ESLICARBAZEPINE ACETATE — 600 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 TABLET in 1 BOTTLE (59746-719-05) · 59746-719-05
- 30 TABLET in 1 BOTTLE (59746-719-30) · 59746-719-30
- 60 TABLET in 1 BOTTLE (59746-719-60) · 59746-719-60
- 90 TABLET in 1 BOTTLE (59746-719-90) · 59746-719-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →